Incyte Corp (INCY)
$90.56 1.48 (1.61%)
19:39 EST INCY Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 19.20B
PE Ratio -119.16
Volume (Avg. Vol.) 930,100
Day's Range 89.32 - 92.52
52-Week Range 62.48 - 110.36
Dividend & Yield N/A (N/A)
INCY Stock Predictions, Articles, and Incyte Corp News
- From InvestorPlace
- From the Web
Biotech stocks had a great run in 2017. The new year could have more big gains ahead. Here are 5 top biotech stocks to buy today.
Incyte Corp (NASDAQ:INCY) is a $22.2 billion in market value member of the Biotechnology GICS industry group where Portfolio Grader's current ranking for INCY puts it 171 among the 349 companies in this industry group, placing it in the top half. INCY is ranked in the third quartile of the sector with a ranking of 402 among the 785 companies in the sector and number 2,601 in the 5000 company Portfolio Grader company universe.
Toxic stocks are exposed to outside shocks and are burdened with high levels of debts. Also, the price of toxic stocks is artificially inflated.
Biotech stocks are surging amid M&A speculation after Gilead agreed to buy Kite Pharma. And these biotechs are moving higher in response.
Why Herbalife Ltd. (HLF), Snap Inc (SNAP) and Incyte Corporation (INCY) Are 3 of Today’s Worst Stocks
Incyte (INCY), Snap (SNAP) and Herbalife (HLF) shareholders should have made it a three-day weekend. Here's why.
Incyte (INCY) stock was up on Thursday on promising results in Phase 1 and Phase 2 studies for one of its lung cancer drugs.
If you own any of these biotech stocks (or are thinking about it), mark these four dates on your calendar. Things are going to get real interesting, real fast.
Why Dish Network Corp (DISH), Snyder’s-Lance Inc (LNCE) and Incyte Corporation (INCY) Are 3 of Today’s Worst Stocks
Incyte (INCY), Dish Network (DISH) and Snyder's-Lance (LNCE) shareholders ended up wishing this past weekend was a four-day trading break.
Eli Lilly (LLY) took a hit Monday after an FDA letter on dosages and safety likely delayed Olumiant's U.S. market entry. But LLY stock still has its virtues.
We have selected 5 Buy-ranked stocks that have outperformed in the current bull market with room to run higher.
Some stocks are graded fairly, but a handful of the most overrated stocks deserve to be called out -- and sold sooner than later.
Higher prices of toxic stocks can be attributed to irrational exuberance or serious fundamental lacuna. Here are 5 stocks to consider selling
The Services sector saw plenty of trading activity today, including the following leaders and losers.
From Market News Video
Navellier RatingsPowered by Portfolio Grader